Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Poliomyelitis
NITAG documentation
2021
Clear all
Type of publications
NITAG documentation
(166)
SAGE documentation
(4)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(230)
Topics
Agenda & Minutes
(2)
Background paper
(27)
Recommendation
(137)
Available to download in languages
English (EN)
(113)
French (FR)
(37)
Spanish (ES)
(12)
German (DE)
(7)
Swedish (SV)
(1)
Regions
Africa
(18)
Americas
(61)
Europe
(74)
South-East Asia
(2)
Western Pacific
(11)
Countries
Diseases
COVID-19
(164)
Poliomyelitis
(2)
Ebola
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Influenza
(5)
Pneumococcal disease
(1)
Rotavirus
(3)
Varicella
(1)
Vaccine topics
Target population
Adults
(3)
Children
(3)
Older adults
(1)
Pregnant women
(4)
Risk group
(2)
Publication date
2021
(166)
2024
(2)
2023
(23)
2022
(81)
2020
(84)
2019
(3)
2018
(3)
2017
(6)
2016
(6)
2015
(1)
2014
(2)
2010
(3)
2009
(1)
2000
(1)
166 results found
2021
∙
STIKO
Decision of the STIKO on the 4th update of the COVID-19 vaccination recommendation and the associated scientific justification - 8 April, 2021
2021
∙
STIKO
Decision of the STIKO on the 5th update of the COVID-19 vaccination recommendation and the associated scientific justification - May 12, 2021
2021
∙
Robert Koch Institut
Decision of the STIKO on the 6th update of the COVID-19 vaccination recommendation and the associated scientific justification - 10 June, 2021
2021
∙
ACIP, Heather Scobie
Emerging SARS-CoV-2 Variants: Considerations for Vaccine - March 1st 2021
2021
∙
ACIP
Epidemiology of COVID-19 in Children and Teens
2021
∙
Sara Oliver, ACIP
EtR Framework: Janssen COVID-19 vaccine
2021
∙
Health Council of the Netherlands
Executive summary of COVID-19 vaccination for young children belonging to clinical risk groups
2021
∙
Health Council of the Netherlands
Executive summary of COVID-19 vaccination of children aged 5 to 11
2021
∙
NACI
Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply - 7 April, 2021
2021
∙
ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Janssen COVID-19 Vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register